Prevalence of female sexual dysfunction and the relationship between climacteric symptoms and female sexual dysfunction in Chinese women with menopause transition stage and postmenopausal stage

doi:10.3969/j.issn.1006-7795.2020.04.001

Abstract

Abstract: Objective To investigate the effects of climacteric symptoms on female sexual dysfunction(FSD) at different reproductive aging stages. Methods A cross-sectional study including 180 cases was conducted among women over 40 years old in the Department of Gynecological Endocrinology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China, from Jun. 2019 to Oct. 2019. According to the 2011 stages of the Reproductive Ageing Workshop (STRAW+10), the subjects were divided into four groups:early menopausal transition stage (group A), late menopausal transition stage (group B), early postmenopausal stage (group C), and late postmenopausal stage (group D). Female climacteric symptoms were evaluated by Modified Kupperman Index (KMI), and FSD was evaluated by Female Sexual Function Index (FSFI). Results With the increase of stages of the reproductive aging, the median age of the subjects increased from 45.5 years to 57.0 years, the median years of cohabitation with their partners increased from 20 years to 23.5 years, the median time of sexual frequency increased from 7 days to 15 days, and the median KMI increased from 9.5 to 15 days (P<0.05). With the increase of stages of the reproductive aging, the prevalence of FSD and sexual desire disorder, sexual arousal disorder, vaginal lubrication disorder, orgasm disorder, sexual satisfaction disorder, and vaginal pain were significantly increased (P<0.05). The prevalence of FSD and sexual desire disorder, sexual arousal disorder, vaginal lubrication disorder, orgasm disorder, sexual satisfaction disorder, and vaginal pain increased with the severity of menopausal symptoms (P<0.05). Conclusion With advanced stage of reproductive aging, FSD was prevalent significantly. The prevalence of FSD was higher in women with menopausal symptoms. The more severe the menopausal symptoms were, the higher the prevalence of FSD was. Climacteric symptoms and their severity are important factors affecting the occurrence of FSD in women over 40 years old. Climacteric symptoms should be actively treated to improve the quality of life of women.

Key words: climacteric, female sexual dysfunction, menopause, women's health

CLC Number:

R711

Ju Rui, Ruan Xiangyan, Xu Xin, Yang Yu, Zhang Luping, Qin Shuang, Wang Binhong, Dou Zhuli, Alfred O. Mueck. Prevalence of female sexual dysfunction and the relationship between climacteric symptoms and female sexual dysfunction in Chinese women with menopause transition stage and postmenopausal stage[J]. Journal of Capital Medical University, 2020, 41(4): 503-507.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2020.04.001

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2020/V41/I4/503

References 16

[1]	Cruz E,Nina V,Figuerêdo E. Climacteric symptoms and sexual dysfunction:association between the Blatt-Kupperman index and the female sexual function index[J]. Rev Bras Ginecol Obstet,2017,39(2):66-71.
[2]	Lou W J,Chen B,Zhu L,et al. Prevalence and factors associated with female sexual dysfunction in Beijing,China[J]. Chin Med J (Engl),2017,130(12):1389-1394.
[3]	American College of Obstetricians and Gynecologists' Committee.Female sexual dysfunction:ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynecologists,Number 213[J]. Obstet Gynecol,2019,134(1):e1-e18.
[4]	金凤羽,阮祥燕,Alfred O. Mueck,等. 医院就诊女性患者性功能障碍调查(附420例资料分析)[J]. 北京医学,2017,39(11):1135-1137.
[5]	王浅浅,阮祥燕,田玄玄,等. 298例围绝经期女性性功能障碍患病率及患病类型调查[J]. 首都医科大学学报,2014,35(4):397-401.
[6]	Harlow S D,Gass M,Hall J E,et al. Executive summary of the Stages of Reproductive Aging Workshop+10:addressing the unfinished agenda of staging reproductive aging[J]. Climacteric,2012,15(2):105-114.
[7]	Ruan X,Cui Y,Du J,et al. Prevalence of climacteric symptoms comparing perimenopausal and postmenopausal Chinese women[J]. J Psychosom Obstet Gynaecol,2017,38(3):161-169.
[8]	Kong F,Wang J,Zhang C,et al. Assessment of sexual activity and menopausal symptoms in middle-aged Chinese women using the menopause rating scale[J]. Climacteric,2019,22(4):370-376.
[9]	Karvonen-Gutierrez C,Kim C. Association of mid-life changes in body size,body composition and obesity status with the menopausal transition[J]. Healthcare,2016,4(3):42.
[10]	Fernandez-Alonso A M,Cuadros J L,Chedraui P,et al. Obesity is related to increased menopausal symptoms among Spanish women[J]. Menopause Int,2010,16(3):105-110.
[11]	Maiorino M I,Bellastella G,Giugliano D,et al. From inflammation to sexual dysfunctions:a journey through diabetes,obesity,and metabolic syndrome[J]. J Endocrinol Investigat,2018,41(11):1249-1258.
[12]	Heidari M,Ghodusi M,Rezaei P,et al. Sexual function and factors affecting menopause:a systematic review[J]. J Menopausal Med,2019,25(1):15.
[13]	Ngai F W. Relationships between menopausal symptoms,sense of coherence,coping strategies,and quality of life[J]. Menopause,2019,26(7):758-764.
[14]	Mostafa T,Mostafa R M,Hassan M M,et al. Female sexual dysfunction among menopausal women[J]. Human Androl,2015,5(2):23-27.
[15]	Delamater L,Santoro N. Management of the perimenopause[J]. Clin Obstetr Gynecol,2018,61(3):419-432.
[16]	Chedraui P,Perez-Lopez F R,San M G,et al. Assessment of sexuality among middle-aged women using the female sexual function index[J]. Climacteric,2009,12(3):213-221.